Advertisement

Topics

Macquarie Group Company Profile

04:17 EDT 25th June 2018 | BioPortfolio

Macquarie Group (ASX: MQG; ADR: MQBKY) is a leading provider of banking, financing, advisory, investment and fund management services. Founded in 1969, Macquarie Group employs more than 13,900 people in 28 countries.


News Articles [421 Associated News Articles listed on BioPortfolio]

MACQUARIE INFRASTRUCTURE SHAREHOLDER ALERT: CLAIMSFILER Reminds Investors with Losses in Excess ...

Macquarie investors should visit us at https://www.claimsfiler.com/cases/view-macquarie-infrastructure-corporation-securities-litigationor call to speak to our claim center toll-free at (844) 367-96...

Mylan (MYL) Holdings Boosted by Macquarie Group Ltd.

Macquarie Group Ltd. boosted its stake in shares of Mylan by 77.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The ...

Macquarie Group Ltd. Acquires 12,000 Shares of Lannett Company, Inc.

Macquarie Group Ltd. boosted its holdings in shares of Lannett Company, Inc. by 24.8% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund o...

Teva Pharmaceutical Industries Ltd (TEVA) Shares Sold by Macquarie Group Ltd.

Macquarie Group Ltd. lowered its position in Teva Pharmaceutical Industries Ltd by 96.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Ex...

MACQUARIE INFRASTRUCTURE SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK ...

If you purchased shares of Macquarie and would like to discuss your legal rights and how this case might affect you and your right to Read more...

Macquarie hebt Ziel für Nike auf 80 US-Dollar - 'Outperform'

Die australische Investmentbank Macquarie hat das Kursziel für die Aktien des Sportartikelherstellers Nike von 72 auf 80 US-Dollar angehoben und die Einstufung auf "Outperform" belassen. Dies schr...

Macquarie belässt Nike auf 'Outperform' - Ziel 80 US-Dollar

Die australische Investmentbank Macquarie hat die Einstufung für die Aktien des Sportartikelherstellers Nike auf "Outperform" mit einem Kursziel von 80 US-Dollar belassen. Dies schrieb Analyst Lau...

Macquarie hebt Ziel für Intel auf 58 Dollar - 'Outperform'

Die australische Investmentbank Macquarie hat das Kursziel für Intel von 55 auf 58 US-Dollar angehoben und die Einstufung auf "Outperform" belassen. Analyst Srini Pajjuri erhöhte in einer am Donne.....

PubMed Articles [1799 Associated PubMed Articles listed on BioPortfolio]

Changes over time in hip fracture risk: greater improvements in men compared to women.

The aim of this study was to determine whether there has been a change in the mean age and age-standardised incidence of minimal trauma hip fractures in the Newcastle and Lake Macquarie population of ...

Group Influences on Engaging Self-Control: Children Delay Gratification and Value It More When Their In-Group Delays and Their Out-Group Doesn't.

Self-control emerges in a rich sociocultural context. Do group norms around self-control influence the degree to which children use it? We tested this possibility by assigning 3- to 5-year-old childre...

An Examination of Group Size and Valence in Delay Discounting of Shared Outcomes.

Previous research has examined delay discounting in a group context, where the outcomes are shared with others. These studies indicate shallow delay discounting in a group context compared to an indiv...

Ameliorating effects of tempol on methotrexate-induced liver injury in rats.

Methotrexate (MTX) is used in the treatment of certain types of cancers and chronic inflammatory illnesses, although the clinical use of MTX is limited due to its adverse effects, the most common of w...

Medulloblastoma with transitional features between Group 3 and Group 4 is associated with good prognosis.

Medulloblastoma, the most common malignant pediatric brain tumor, is a heterogeneous disease, with the existence of at least four molecular types: Wingless (WNT), Sonic Hedgehog (SHH), Group 3 and Gro...

Clinical Trials [3703 Associated Clinical Trials listed on BioPortfolio]

Internet-Delivered Cognitive Behavior Therapy for Anxiety and Depression Amongst French Canadians

This study represents Phase II of a research program involving an international collaboration with Macquarie University (Sydney, Australia) to implement an Internet-based cognitive behavio...

The Influence of Hypotensive Drugs on Mineral Status in Experimental and Clinical Studies

The aim of the study was to evaluate the effects of hypotensive treatment combined with a higher zinc supply in the diet and supplements on the mineral status and selected biochemical para...

Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-828 in Healthy Participants

The purpose of this study is to evaluate the safety and tolerability of single oral doses of TAK-828 in healthy non-Japanese and Japanese participants.

Technical Development of Multi-Parametric Renocerebral MRI

The purpose of the study is to investigate the associations of the age-related changes in the brain, kidneys and cognitive performance in healthy adults by utilizing multiple anatomic and ...

Electro-acupuncture and Flumazenil's Effect on Sedation

Object: To explore the mechanism of the electro-acupuncture (EA) induced sedation effect in general anaesthesia through investigating the role of the Benzodiazepines-GABA system. Method: ...

Companies [1619 Associated Companies listed on BioPortfolio]

Macquarie Capital

Macquarie Group (Macquarie) is a global provider of banking, financial, advisory, investment and funds management services. Founded in 1969, Macquarie employs more than 14,400 peo...

Macquarie Group

Macquarie Group (ASX: MQG; ADR: MQBKY) is a leading provider of banking, financing, advisory, investment and fund management services. Founded in 1969, Macquarie Group employs mor...

Proteome Systems Limited.

Proteome Systems commenced operations in January 1999. The Company was founded by Professor Keith Williams and a core team of internationally recognized scientists from the Macquarie University Centre...

Professor John Mathews and Dr. Hao Tan

Professor Mathews is professor of strategic management at Macquarie University in Sydney, Australia. As a specialist in technology and innovation, he is interested in the renewable energy industries a...

W2 Group, Inc.

W2 Group is a global marketing services ecosystem that helps CMOs in their new role as builders of communities and content aggregators. W2 Group companies, including Digital ...

More Information about "Macquarie Group" on BioPortfolio

We have published hundreds of Macquarie Group news stories on BioPortfolio along with dozens of Macquarie Group Clinical Trials and PubMed Articles about Macquarie Group for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Macquarie Group Companies in our database. You can also find out about relevant Macquarie Group Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record